Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $119.02M.
ENTERPRISE VALUE (EV)
$119.02M
Coherus Oncology, Inc.
Market Cap
$170.85M
Enterprise Value (EV)
$119.02M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Coherus Oncology, Inc. (CHRS) | $170.85M | $119.02M |
| Compass Therapeutics, Inc. (CMPX)vs › | $171.61M | $145.79M |
| Precision BioSciences, Inc. (DTIL)vs › | $173.34M | $115.36M |
| Cue Biopharma, Inc. (CUE)vs › | $177.29M | $168.71M |
| Canton Strategic Holdings Inc (CNTN)vs › | $178.54M | $141.30M |
| Inogen, Inc. (INGN)vs › | $161.12M | $89.64M |
| ALX Oncology Holdings Inc. (ALXO)vs › | $158.25M | $145.26M |
| Journey Medical Corporation (DERM)vs › | $183.71M | $183.61M |
| Cardiol Therapeutics Inc. (CRDL)vs › | $155.04M | $136.75M |
| Anavex Life Sciences Corp. (AVXL)vs › | $154.76M | $36.44M |
Market Cap
$170.85M
Total Debt
$37.05M
Cash
$88.88M
Enterprise Value
$119.02M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Why use EV instead of Market Cap?
